Metabolic disease in 10 patients with sudden unexpected death in infancy or acute life-threatening events

Tomoo Takahashi1, Kenji Yamada1, Hironori Kobayashi1

  • 1Department of Pediatrics, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.

Insights

Inborn errors of metabolism are linked to sudden unexpected death in infancy (SUDI) and acute life-threatening events (ALTE). Early metabolic testing is crucial for infants with SUDI or ALTE to identify these conditions.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Genetics

Background:

  • Sudden unexpected death in infancy (SUDI) and acute life-threatening events (ALTE) pose significant diagnostic challenges.
  • Inborn errors of metabolism (IEMs) are increasingly recognized as potential underlying causes for these critical events.
  • Organic acidemia and fatty acid oxidation disorders are specific IEMs that warrant investigation.

Purpose of the Study:

  • To investigate the association between IEMs and SUDI/ALTE.
  • To evaluate the clinical features and diagnostic findings in infants presenting with SUDI or ALTE who have underlying metabolic disorders.

Main Methods:

  • Retrospective analysis of infants aged 7 days to 3 years diagnosed with SUDI or ALTE between 2004 and 2013.
  • Diagnosis of IEMs using gas chromatography-mass spectrometry (GC/MS) and/or tandem mass spectrometry (MS/MS).
  • Evaluation of clinical presentation, neonatal history, and routine laboratory findings during the acute phase.

Main Results:

  • IEMs were identified in 3 of 196 SUDI cases and 7 of 167 ALTE cases.
  • Nine of the ten affected infants exhibited neonatal poor feeding, somnolence, and/or infectious symptoms like cough, fever, or vomiting.
  • Key laboratory abnormalities included hyperammonemia, liver dysfunction, elevated creatine kinase, acidosis, ketonuria/ketonemia, and hypoglycemia.

Conclusions:

  • IEMs are an important consideration in the differential diagnosis of SUDI and ALTE.
  • Detailed neonatal history and targeted laboratory investigations, including metabolic screening (GC/MS/MS), are essential in the emergency evaluation of infants with SUDI/ALTE.
  • Prompt identification of IEMs can guide appropriate management and potentially prevent future events.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
2.4K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.8K